Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extension Study of Vismodegib in Patients Previously Treated With Vismodegib
NCT00959647Phase 2Completed
- Sponsor
- Genentech
- Start
- Sep 2009
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vismodegib in ovarian cancer, basal cell carcinoma (BCC), colorectal cancer (CRC), sponsored by Genentech. Started Sep 2009; status: completed.
02
Drugs
vismodegib
03
Conditions
ovarian cancerbasal cell carcinoma (BCC)colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00959647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00959647.